Methylation of the HACE1 gene is frequently detected in hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 60, Issue 124, 2013, Pages 781-783

  Sakata, Makiko ^a   Yokomizo, Kazuaki ^a   Kitamura, Yohei ^a   Sakuraba, Kazuma ^a   Shirahata, Atsushi ^a   Goto, Tetsuhiro ^a   Mizukami, Hiroki ^a   Saito, Mitsuo ^a   Ishibashi, Kazuyoshi ^a   Kigawa, Gaku ^a   Nemoto, Hiroshi ^a   Hibi, Kenji ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

HACE1; Hepatocellular carcinoma; Quantitative methylation specific PCR

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; HACE1 TUMOR GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; TUMOR GENE;

AGED; CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84879557442     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10439     Document Type: Article

References (24)

1. Parkin DM, Whelan SL, Ferlay J, et al., eds. Cancer Incidence in Five Continents. Volume VII. Lyon, France: International Agency for Research on Cancer, 1997.
2. Tabor E: Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 1994; 42:357-365.
3. Nishida N, Fukuda Y, Komeda T, et al.: Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 1994; 54:3107-3110. (Pubitemid 24208910)
4. de La Coste A, Romagnolo B, Billuart P, et al.: Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998; 95:8847-8851. (Pubitemid 28350577)
5. Hui AM, Sakamoto M, Kanai Y, et al.: Inactivation of p16INK4 in hepatocellular carcinoma. Hepatology 1996; 24:575-579.
6. Merlo A, Herman JG, Mao L, et al.: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1:686-692.
7. Herman JG, Baylin SB: Promoter-region hypermethylation and gene silencing in human cancer. Curr Top Microbiol Immunol 2000; 249:35-54. (Pubitemid 30133492)
8. Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 2001; 61:3225-3229. (Pubitemid 32695003)
9. Yoshikawa H, Matsubara K, Qian GS, et al.: SOCS-1, a negative regulator of the JAK/STAT pathway is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 2001; 28:29-35. (Pubitemid 32405812)
10. Tchou JC, Lin X, Freije D, et al.: GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. Int J Oncol 2000; 16:663-676.
11. Yang B, Guo M, Herman JG, Clark DP: Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2002; 163:1101-1107.
12. Okochi O, Hibi K, Sakai M, et al.: Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis. Clin Cancer Res 2003; 9:5295-5298. (Pubitemid 37413582)
13. Hyytinen ER, Saadut R, Chen C, et al.: Defining the region(s) of deletion at 6q16-q22 in human prostate cancer. Genes Chromosomes Cancer 2002; 34:306-312. (Pubitemid 34553309)
14. Inoue M, Marx A, Zettl A, Ströbel P, Müller-Hermelink HK, Starostik P: Chromosome 6 suffers frequent and multiple aberrations in thymoma. Am J Pathol 2002; 161:1507-1513.
15. Orphanos V, McGown G, Hey Y, et al.: Allelic imbalance of chromosome 6q in ovarian tumours. Br J Cancer 1995; 71:666-669.
16. Utada Y, Haga S, Kajiwara T, et al.: Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3. Jpn J Cancer Res 2000; 91:293-300. (Pubitemid 30198169)
17. Zhang Y, Matthiesen P, Harder S, Siebert R, et al.: A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer 2000; 27:52-58.
18. Zhang L, Anglesio MS, O'Sullivan M, et al.: The E3 ligase HACE1 is a critical chromosome 6q21 rumor suppressor involved in multiple cancers. Nat Med 2007; 13:1060-1069. (Pubitemid 47517503)
19. Hibi K, Sakata M, Sakuraba K, et al.: Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer. Anticancer Res 2008; 28:1581-1584. (Pubitemid 351892933)
20. Sakata M, Kitamura Y, Sakuraba K, et al.: Methylation of HACE1 in gastric carcinoma. Anticancer Res 2009; 9:2227-2229.
21. Hibi K, Taguchi M, Nakayama H, et al.: Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 2001; 7:3135-3138. (Pubitemid 32963835)
22. Fiorentino M, Altimari A, D'Errico A, et al.: Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma. Clin Cancer Res 2000; 6:3966-3972.
23. Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N: Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma. Oncology 2000; 59:68-74. (Pubitemid 30435839)
24. Zhou L, Cheng X, Connolly BA, Dickman MJ, Hurd PJ, Hornby DP: Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. J Mol Biol 2002; 321:591-599. (Pubitemid 36124798)